Magnetic Resonance Imaging to Assess Changes in Meniscus Vascularity
MOVE
1 other identifier
interventional
48
0 countries
N/A
Brief Summary
The menisci in the knee joint are important for normal functioning of the knee. Meniscus tears are amongst the commonest of injuries to the knee. The pattern and blood supply of the meniscus tears determines the treatment plan and outcome. The surgeon identifies the blood supply to the meniscus tear area during the arthroscopy(key hole operation) and decides the treatment option ie repair versus partial meniscectomy. This study aims to identify any changes that occur in the meniscus blood supply. The following are the main aims of the 'MOVE'study-
- 1.Use of non-invasive methods ie MRImaging to assess meniscus vascularity to preoperatively plan treatment and advice patient on recovery.
- 2.The study would assess changes in meniscus blood supply depending on age of the patient.
- 3.The study aims to assess the alteration in meniscus blood supply following an arthroscopic(key hole) meniscal repair operation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 9, 2015
CompletedFirst Posted
Study publicly available on registry
February 13, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedFebruary 19, 2016
February 1, 2016
3 years
February 9, 2015
February 18, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary outcome is to assess meniscus vascularity in-vivo by use of MR imaging technique.
6 months
Study Arms (4)
Group One patients in age group 18--20 years,
NO INTERVENTION1. Patients should be aged 18--20 years or 35--45years 2. Asymptomatic knee for past 6 months. 3. Painless flexion-extension movements at knee joint.
Group Two patients in age group 35-45 years,
ACTIVE COMPARATOR1. Patients should be aged 18--20 years or 35--45years 2. Asymptomatic knee for past 6 months. 3. Painless flexion-extension movements at knee joint.
Group Three Patients aged 75
ACTIVE COMPARATOR1. Patients should be aged 75 or older 2. Knee X-ray showing no more than Kellgren-Lawrence grade II osteoarthrtis 3. No clinical suspicion of meniscus tear 4. Painless flexion-extension movements at knee joint.
Group Four, any age due to undergo a surgical meniscus repair
ACTIVE COMPARATOR1\. Patients should have presented with clinical signs to suggest meniscus tear indicating potential need for surgical meniscus repair
Interventions
Eligibility Criteria
You may qualify if:
- Patients should be aged 18-20 years or 35-45years
- Asymptomatic knee for past 6 months.
- Painless flexion-extension movements at knee joint.
- Patients should be aged 75 or older
- Knee X-ray showing no more than Kellgren-Lawrence grade II osteoarthrtis
- No clinical suspicion of meniscus tear
- Painless flexion-extension movements at knee joint.
- \. Patients should have presented with clinical signs to suggest meniscus tear indicating potential need for surgical meniscus repair.
You may not qualify if:
- Proven Polyarthritis / Polyarthralgia secondary to Rheumatoid arthritis, Gout, Lupus, Ankylosing Spondylosis, Psoriatic arthritis
- Any previous surgical procedure(open or arthroscopic) involving the knee joint.(baring the current meniscus repair in Group IV participants)
- Patients unable to give informed consent.
- Patients with contraindication for MR Imaging - Metal implants, prosthetic heart valves, pacemakers, metal foreign bodies, VP shunts, pregnancy, cochlear implant, metal clips in the brain, Patients with static tremor i.e. Parkinson's disease.
- Patients with contraindications for contrast agent - Renal impairment, Previous allergic reaction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 9, 2015
First Posted
February 13, 2015
Study Start
June 1, 2012
Primary Completion
June 1, 2015
Last Updated
February 19, 2016
Record last verified: 2016-02